Trademark Overview
On Monday, July 28, 2025, a trademark application was filed for XYME with the United States Patent and Trademark Office. The USPTO has given the XYME trademark a serial number of 99306692. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 28, 2025. This trademark is owned by Xyme Limited. The XYME trademark is filed in the Chemical Products, Lubricant & Fuel Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:
Software for the design of enzymes; software for the design of de novo enzymes; software for the design of catalytic sites of enzymes; software for the design of tertiary structure of enzymes; software to optimise properties of enzymes including, but not limited to, solubility and stability; software to predict enzyme structure; software to design and predict stabilising enzyme conformations during catalysis; artificial intelligence and machine learning models for the design of de novo enzymes; artificial intelligence and machine learning models for the design of catalytic sites of enzymes; artificial intelligence and machine learning models for the design of tertiary structure of enzymes; artificial intelligence and machine learning models for the design of properties of enzymes including, but not limited to, solubility and stability; artificial intelligence and machine learning models for the prediction of enzyme structure; artificial intelligence and machine learning models for the ...
Biofuels; biomass fuel; fuels from biological sources; alcohol [fuel]; carburants/motor fuel; diesel oil/gas oil; ethanol [fuel]; fuel gas; fuel oil/combustible oil; fuel with an alcohol base; kerosene; naphtha
De novo enzymes designed by AI; enzymes with AI-designed catalytic sites; enzymes with AI-designed tertiary structure; purified enzymes for catalysis of chemical reactions; enzymes for the production of chemical products; enzymes for novel synthetic pathways; purified enzymes for treatment of diseases; purified enzymes for the production of biofuels; enzymes for carbon dioxide capture and conversion; enzymes for biocatalysis, purified enzymatic non-living organism in the form of a catalyst solution for chemical and biochemical processes; purified enzymes for degradation of materials; aqueous and non-aqueous enzyme solutions for industrial use in catalytic reactors; aqueous and non-aqueous enzyme solutions for therapeutic and medical applications; aqueous and non-aqueous enzyme solutions for technical use; aqueous and non-aqueous enzyme solutions for chemical catalysis and biocatalysis; enzymes immobilised on support materials such as, but not limited to, nanoparticles, chitosan and col...
Design of enzymes; design of de novo enzymes; design of catalytic sites of enzymes; design of tertiary structure of enzymes; technical design and consultancy services relating to the optimisation of properties of enzymes including, but not limited to, solubility and stability; technical design and consultancy services relation to the prediction of enzyme structure; technical design and consultancy services relating to the design and prediction of enzyme conformations during catalysis; software as a service for the design of enzymes; software as a service for the design of de novo enzymes; software as a service for the design of catalytic sites of enzymes; software as a service for the design of tertiary structure of enzymes; software as a service featuring software to optimise properties of enzymes including, but not limited to, solubility and stability; software as a service featuring software to predict enzyme structure; software as a services featuring software to design and predict...
